In the world of medical diagnostics, subtle abnormalities in blood tests can be a gateway to understanding deeper health issues. Ozelle, a key player in medical technology, is at the forefront of this innovation with their latest device, the O-Cyte 1, showcased at MEDICA 2026. This groundbreaking automated hematology analyzer features advanced cell imaging capabilities that revolutionize how blood tests are interpreted.
Blood tests, particularly Complete Blood Counts (CBC), are fundamental in diagnosing various illnesses. However, when results yield unusual findings, traditional procedures might fall short in providing clarity. The O-Cyte 1 addresses this gap by incorporating cell imaging directly into routine CBC testing. This integration empowers laboratory professionals with high-resolution images that serve not only as diagnostic tools but also enrich the overall quality of patient care.
The technology behind O-Cyte 1 leverages Complete Blood Morphology (CBM), a unique feature combining cell imaging with Artificial Intelligence (AI)-assisted morphology analysis. This ensures a thorough differentiation of leukocytes into seven distinct categories, providing a clearer perspective of patient health. When a CBC test indicates abnormalities, laboratory specialists can easily access corresponding cell images for further examination, making the diagnostic process more comprehensive.
In busy laboratories, efficiency is paramount. The O-Cyte 1 is designed to blend seamlessly into existing workflows. It supports batch loading of 25 sample tubes, automatic sample identification via barcodes, and prioritized processing for urgent samples—capabilities that are crucial in high-demand settings. Impressively, a single unit processes up to 60 tests per hour, while six connected machines can manage 360 tests per hour, significantly boosting laboratory capacity during peak times.
Maintenance is another critical aspect for laboratory operations. Conventional analyzers often require time-consuming cleaning due to reusable fluid pathways. Ozelle’s innovative solution integrates essential wet components into replaceable reagent kits, greatly reducing internal cleaning burdens. Additionally, built-in self-test features and replaceable modules simplify troubleshooting and maintenance, enabling efficient client service.
"Our mission was to embed cell morphology into routine CBC assessments while ensuring optimal laboratory efficiency," explained Jie Du, co-founder and Head of R&D at Ozelle. "This required us to design the entire system with a focus on sample handling, image evaluation, and maintenance."
For clinics and decentralized testing sites, O-Cyte 1 opens doors to broader testing options in limited spaces with minimal maintenance demands. Ozelle’s EHBT analyzer series caters to human medicine, covering hematology, cell imaging, immunoassays, and dry biochemistry. In veterinary medicine, the EHVT series excels in hematology, digital cell morphology, immunoassays, biochemistry, and more. Both lines emphasize reliable performance, user-friendliness, and minimal upkeep.
Those attending MEDICA 2026 can witness live demonstrations until November 19 at Hall 1, Stand D63. Visitors are encouraged to engage with the Ozelle team for insights into clinical applications and sales opportunities.
For more information about Ozelle and their groundbreaking technologies, visit
Ozelle's website or reach out via email at [email protected].